Latest Observability News

Invion Limited secures a pivotal FDA Orphan Drug Designation for its lead candidate INV043, targeting anal cancer with promising preclinical results and a fast-tracked development path.

LTR Pharma’s intranasal ED treatment SPONTAN achieves peak effect up to five times faster than oral tablets, according to new peer-reviewed clinical data published in a leading European journal.

TPG Telecom has revealed a significant cyber incident involving unauthorized access to iiNet’s order management system, potentially exposing sensitive customer data. The breach, traced to stolen employee credentials, is currently contained but raises questions about future security measures.

Alma Metals has initiated a 900m deep diamond drilling program at its Briggs Copper Project, targeting a key geophysical anomaly adjacent to existing resources. Supported by a $250,000 Queensland Government grant, early drilling has revealed visible copper mineralisation, with assay results anticipated next quarter.

Encounter Resources reports exceptional rare earth and niobium assay results from diamond drilling at its Crean prospect, reinforcing the Aileron project's status as a critical minerals hotspot in Western Australia.

Universal Biosensors has extended the due diligence period with major investor Viburnum Funds as it continues to negotiate a secured loan facility, with no binding commitment yet reached.

Apiam Animal Health has received a non-binding indicative proposal from Adamantem Capital Management to acquire the company at $0.88 per share, sparking a potential shift in ownership for the veterinary services leader.

Ampol Limited posted a statutory net loss of $25.3 million for the first half of 2025, impacted by significant items and inventory losses, while continuing to invest in electric vehicle infrastructure and fuel supply chain enhancements.

Kaili Resources has received official approval to begin a targeted drilling program for rare earth elements across three tenements in South Australia’s Limestone Coast region, advancing its exploration ambitions in a promising mineral province.

Ryder Capital Limited has delivered a robust financial performance for the year ended 30 June 2025, reporting $17 million in net tangible assets and maintaining a fully franked dividend policy. The company’s audited results highlight strong governance and transparent related party transactions amid a complex valuation environment.

Nyrada Inc has responded to ASX inquiries confirming the timely and compliant disclosure of positive safety data from its Phase I clinical trial of Xolatryp. The company detailed the timeline of its awareness and release of information, affirming adherence to continuous disclosure rules.

Resouro Strategic Metals reports strong assay results from 18 auger drill holes at its Tiros Northern Block in Brazil, confirming significant near-surface titanium and rare earth mineralization. These findings complement the company’s existing resource base and support ongoing development efforts at the adjacent Central Block.